Evaluation of the use of High Efficacy Treatments (HETs) in patients with relapsing remitting multiple sclerosis in Argentina

被引：0

作者：

Alonso, R. ^{[1
]}

Casas, M. ^{[1
]}

Lazaro, L. ^{[1
]}

Pita, C. ^{[1
]}

Cohen, L. ^{[1
]}

Liguori, N. Fernandez ^{[1
,2
]}

Rojas, J. I. ^{[3
]}

Pappolla, A. ^{[3
]}

Patrucco, L. ^{[3
]}

Cristiano, E. ^{[3
]}

Burgos, M. ^{[4
]}

Vrech, C. ^{[5
]}

Piedrabuena, R. ^{[6
]}

Lopez, P. ^{[7
]}

Deri, N. ^{[8
]}

Luetic, G. ^{[9
]}

Miguez, J. ^{[10
]}

Cabrera, M. ^{[11
]}

Martinez, A. ^{[12
]}

Zanga, G. ^{[13
]}

Tkachuk, V. ^{[14
]}

Tizio, S. ^{[15
]}

Contentti, E. Carnero ^{[7
]}

Knorre, E. ^{[16
]}

Leguizamon, F. ^{[16
]}

Mainella, C. ^{[17
]}

Nofal, P. ^{[18
]}

Liwacki, S. ^{[19
]}

Hryb, J. ^{[20
]}

Menichini, M. ^{[9
]}

Pestchanker, C. ^{[21
]}

Garcea, O. ^{[1
]}

Silva, B. ^{[1
,10
]}

机构：

[1] Ramos Mejia Hosp, Multiple Sclerosis Univ Ctr CUEM, Neurol, Buenos Aires, Argentina

[2] Sanat Guemes, Neurol, Buenos Aires City, Argentina

[3] Ctr Esclerosis Multiple Buenos Aires, Buenos Aires City, Argentina

[4] Hosp San Bernardo, Salta, Argentina

[5] Sanat Allende, Cordoba, Argentina

[6] Clin Univ Reina Fabiola, Cordoba, Argentina

[7] Hosp Aleman, Neurol, Buenos Aires City, Argentina

[8] Ctr Invest Diabaid, Buenos Aires City, Argentina

[9] Inst Neurociencias Rosario, Rosario, Argentina

[10] Hosp Italiano Buenos Aires, Buenos Aires City, Argentina

[11] Hosp Mil, Buenos Aires, Argentina

[12] Hosp Posadas, Buenos Aires, Argentina

[13] UA Cesar Milstein, CABA, Buenos Aires, Argentina

[14] Hosp Clin Jose De Sean Martin, CABA, Buenos Aires City, Argentina

[15] Hosp Espanol La Plata, La Plata, Argentina

[16] Hosp Alvarez, Buenos Aires City, Argentina

[17] Hosp Espanol Rosario, Rosario, Argentina

[18] Hosp Clin Ntra Sra Carmen, San Miguel De Tucuman, Argentina

[19] Hosp Cordoba, Cordoba, Argentina

[20] Hosp Durand, Buenos Aires City, Argentina

[21] Hosp Cent San Luis, San Luis, Argentina

来源：

MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP1050

引用

页码：841 / 842

页数：2

共 50 条

[1] Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina
Alonso, Ricardo
Casas, Magdalena
Lazaro, Luciana
Liguori, Nora Fernandez
Pita, Cecilia
Cohen, Leila
Rojas, Juan Ignacio
Pappolla, Agustin
Patrucco, Liliana
Cristiano, Edgardo
Burgos, Marcos
Vrech, Carlos
Piedrabuena, Raul
Pablo, Lopez
Deri, Norma
Luetic, Geraldine
Miguez, Jimena
Cabrera, Mariela
Martinez, Alejandra
Zanga, Gisela
Tkachuk, Veronica
Tizio, Santiago
Contentti, Edgar Carnero
Knorre, Eduardo
Leguizamon, Felisa
Mainella, Carolina
Nofal, Pedro
Liwacki, Susana
Hryb, Javier
Menichini, Maria
Pestchanker, Claudia
Garcea, Orlando
Silva, Berenice
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
[2] Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments
Forci, B.
Mariottini, A.
Mechi, C.
Magnani, E.
Barilaro, A.
Falcini, M.
Palumbo, P.
Massacesi, L.
Repice, A. M.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 490 - 490
[3] Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait
Alroughani, R.
Ahmed, S. F.
Behbehani, R.
Al-Hashel, J.
CLINICAL NEUROLOGY AND NEUROSURGERY, 2014, 119 : 17 - 20
[4] New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis
Fox, Edward J.
Rhoades, Robert W.
CURRENT OPINION IN NEUROLOGY, 2012, 25 : S11 - S19
[5] Regional efficacy of fingolimod in relapsing remitting multiple sclerosis
Bogdan, I.
Warren, C.
Koniotes, A.
Ruffer, G.
Newell, B.
Fisniku, L.
Bremner, S.
Gabel, M. C.
Rashid, W.
EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 192 - 192
[6] Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments
Forci, B.
Mariottini, A.
Mechi, C.
Magnani, E.
Barilaro, A.
Massacesi, L.
Repice, A.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 874 - 874
[7] Newer versus older treatments for relapsing remitting multiple sclerosis
WeinstockGuttman, B
Cohen, JA
DRUG SAFETY, 1996, 14 (02) : 121 - 130
[8] Current and future treatments for relapsing-remitting multiple sclerosis
Birnbaum, Gary
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2010, 13 (02) : 214 - 225
[9] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
Arnal-Garcia, Carmen
Rosa Garcia-Montero, Ma
Malaga, Ignacio
Millan-Pascual, Jorge
Oliva-Nacarino, Pedro
Ramio-Torrenta, Lluis
Oreja-Guevara, Celia
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
[10] Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina
Ignacio Rojas, Juan
Patrucco, Liliana
Alonso, Ricardo
Garcea, Orlando
Deri, Norma
Carnero Contentti, Edgar
Lopez, Pablo A.
Pablo Pettinicchi, Juan
Caride, Alejandro
Cristiano, Edgardo
CLINICAL NEUROPHARMACOLOGY, 2022, 45 (03) : 45 - 51

← 1 2 3 4 5 →